CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Kimia Farma (Persero) Tbk PT Company Snapshot
Kimia Farma (Persero) Tbk PT operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kimia Farma (Persero) Tbk PT with three other pharmaceutical manufacturers in Asia: Tianjin Chase Sun Pharmaceutical Company Limited of China (2018 sales of 4.22 billion Chinese Renmimbi [US$596.68 million] of which 51% was Granules), Zhejiang Jianfeng Group Company Limited of China (3.36 billion Chinese Renmimbi [US$474.95 million] of which 48% was Cement/Construction Materials), and Shanxi Zhendong Pharmaceutical Co Ltd which is also based in China (3.42 billion Chinese Renmimbi [US$483.07 million] of which 109% was Medicine Manufacture and Sale).

Sales Analysis. Kimia Farma (Persero) Tbk PT reported sales of 7.45 trillion Indonesian Rupiahs (US$533.71 million) for the year ending December of 2018. This represents an increase of 21.7% versus 2017, when the company's sales were 6.13 trillion Indonesian Rupiahs. Sales at Kimia Farma (Persero) Tbk PT have increased during each of the previous five years (and since 2013, sales have increased a total of 71%). Sales of Retail saw an increase of 26.0% in 2018, from 3.27 trillion Indonesian Rupiahs to 4.13 trillion Indonesian Rupiahs. Not all segments of Kimia Farma (Persero) Tbk PT experienced an increase in sales in 2018: sales of Manufacturing fell 16.0% to 272.12 billion Indonesian Rupiahs.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Kimia Farma (Persero) Tbk PT
  Stock Performance Chart for Kimia Farma (Persero) Tbk PT
 
  Stock Data: Recent Stock Performance:
  Current Price (9/13/2019): 2,980.00
(Figures in Indonesian Rupiahs)
1 Week 2.4%   13 Weeks -12.4%  
4 Weeks -12.4%   52 Weeks 26.3%  
 
Kimia Farma (Persero) Tbk PT Key Data:
  Ticker: KAEF Country: Indonesia
  Exchanges: JAK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2018 Sales 7,454,114,741,189
(Year Ending Jan 2019).
Employees: 10,998
  Currency: Indonesian Rupiahs Market Cap: 16,550,920,000,000
  Fiscal Yr Ends: December Shares Outstanding: 5,554,000,000
  Share Type: Series B Closely Held Shares: 5,000,125,000
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.